Federal Contractor Profile
Janssen Pharmaceuticals, INC.
Federal contracting record: $944M obligated across 2 awards from 1 agencies, FY 2016–2026.
Company Profile
UEI (Unique Entity Identifier)
RDJSZL3THV47
CAGE Code
78CR4
Parent Organization
Johnson & Johnson Healthcare
Address
920 ROUTE 202, RARITAN, NJ, 088691420
First Federal Award
Dec 8, 2015
Most Recent Award
Apr 20, 2026
Federal Sales Analytics
Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.
Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).
Top Federal Agencies
- $944M
Department of Health and Human Services
100.0% of total obligations
Top NAICS Activity
- $944M
541711
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
2 awards
Recent Federal Awards
| Date | Agency | NAICS | Description | Amount |
|---|---|---|---|---|
| Mar 15, 2021 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | ASPR-17-03390 -- JANSSEN INFLUENZA PORTFOLIO -- ADVANCED DEVELOPMENT CANDIDATES (OTHER TRANSACTIONAL AUTHORITY) | $32M |
| Nov 13, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | ASPR-17-03390 -- JANSSEN INFLUENZA PORTFOLIO -- ADVANCED DEVELOPMENT CANDIDATES (OTHER TRANSACTIONAL AUTHORITY) | $454M |
| Aug 20, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | ASPR-17-03390 -- JANSSEN INFLUENZA PORTFOLIO -- ADVANCED DEVELOPMENT CANDIDATES (OTHER TRANSACTIONAL AUTHORITY) | $85M |
| May 12, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF | $35M |
| Mar 27, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | ASPR-17-03390 -- JANSSEN INFLUENZA PORTFOLIO -- ADVANCED DEVELOPMENT CANDIDATES (OTHER TRANSACTIONAL AUTHORITY) | $456M |
| Mar 20, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | ASPR-17-03390 -- JANSSEN INFLUENZA PORTFOLIO -- ADVANCED DEVELOPMENT CANDIDATES (OTHER TRANSACTIONAL AUTHORITY) | $148M |
| Dec 27, 2018 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | ASPR-17-03390 -- JANSSEN INFLUENZA PORTFOLIO -- ADVANCED DEVELOPMENT CANDIDATES (OTHER TRANSACTIONAL AUTHORITY) | $41M |
| Jan 13, 2018 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF | $24M |
| Sep 5, 2017 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF | $9.9M |
| Aug 15, 2017 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | ASPR-17-03390 -- JANSSEN INFLUENZA PORTFOLIO -- ADVANCED DEVELOPMENT CANDIDATES (OTHER TRANSACTIONAL AUTHORITY) | $44M |
| May 13, 2016 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF | $1.9M |
| Apr 4, 2016 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | 541711 | IGF::OT::IGF | $2.1M |
| Dec 8, 2015 | Department of Health and Human ServicesOFF ASST SEC ADM AND MGMT | 541711 | IGF::OT::IGF | $2.8M |
Related Contractors
Other companies active in NAICS 541711 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY.
Track Janssen Pharmaceuticals, INC. Recompetes Before They Post
Mindy monitors Janssen Pharmaceuticals, INC.'s active contracts and alerts you 12 months before they expire — so you can position to compete on recompete.
Get Free Recompete Alerts